[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Rabies Treatment Market Report 2017

August 2017 | 97 pages | ID: UA7B042E2DCEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Rabies Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Rabies Treatment in these regions, from 2012 to 2022 (forecast).
United States Rabies Treatment market competition by top manufacturers/players, with Rabies Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Cadila Healthcare
  • GlaxoSmithKline
  • Merial
  • Sanofi
  • Merck
  • Pfizer
  • Bayer
  • AstraZeneca
  • Amneal Pharmaceuticals
  • Anergis
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • Cell culture vaccines (CCVs)
  • Rabies immunoglobulin (RIGs)
  • Nerve tissue vaccines? (NTVs)
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Rabies Treatment for each application, including
  • Pre-exposure prophylaxis
  • Post-exposure prophylaxis
United States Rabies Treatment Market Report 2017

1 RABIES TREATMENT OVERVIEW

1.1 Product Overview and Scope of Rabies Treatment
1.2 Classification of Rabies Treatment by Product Category
  1.2.1 United States Rabies Treatment Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Rabies Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Cell culture vaccines (CCVs)
  1.2.4 Rabies immunoglobulin (RIGs)
  1.2.5 Nerve tissue vaccines? (NTVs)
1.3 United States Rabies Treatment Market by Application/End Users
  1.3.1 United States Rabies Treatment Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Pre-exposure prophylaxis
  1.3.3 Post-exposure prophylaxis
1.4 United States Rabies Treatment Market by Region
  1.4.1 United States Rabies Treatment Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Rabies Treatment Status and Prospect (2012-2022)
  1.4.3 Southwest Rabies Treatment Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Rabies Treatment Status and Prospect (2012-2022)
  1.4.5 New England Rabies Treatment Status and Prospect (2012-2022)
  1.4.6 The South Rabies Treatment Status and Prospect (2012-2022)
  1.4.7 The Midwest Rabies Treatment Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Rabies Treatment (2012-2022)
  1.5.1 United States Rabies Treatment Sales and Growth Rate (2012-2022)
  1.5.2 United States Rabies Treatment Revenue and Growth Rate (2012-2022)

2 UNITED STATES RABIES TREATMENT MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Rabies Treatment Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Rabies Treatment Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Rabies Treatment Average Price by Players/Suppliers (2012-2017)
2.4 United States Rabies Treatment Market Competitive Situation and Trends
  2.4.1 United States Rabies Treatment Market Concentration Rate
  2.4.2 United States Rabies Treatment Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Rabies Treatment Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES RABIES TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Rabies Treatment Sales and Market Share by Region (2012-2017)
3.2 United States Rabies Treatment Revenue and Market Share by Region (2012-2017)
3.3 United States Rabies Treatment Price by Region (2012-2017)

4 UNITED STATES RABIES TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Rabies Treatment Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Rabies Treatment Revenue and Market Share by Type (2012-2017)
4.3 United States Rabies Treatment Price by Type (2012-2017)
4.4 United States Rabies Treatment Sales Growth Rate by Type (2012-2017)

5 UNITED STATES RABIES TREATMENT SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Rabies Treatment Sales and Market Share by Application (2012-2017)
5.2 United States Rabies Treatment Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES RABIES TREATMENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Cadila Healthcare
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Rabies Treatment Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Cadila Healthcare Rabies Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline
  6.2.2 Rabies Treatment Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GlaxoSmithKline Rabies Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merial
  6.3.2 Rabies Treatment Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merial Rabies Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sanofi
  6.4.2 Rabies Treatment Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sanofi Rabies Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Merck
  6.5.2 Rabies Treatment Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Merck Rabies Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Pfizer
  6.6.2 Rabies Treatment Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Pfizer Rabies Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Bayer
  6.7.2 Rabies Treatment Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bayer Rabies Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 AstraZeneca
  6.8.2 Rabies Treatment Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 AstraZeneca Rabies Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Amneal Pharmaceuticals
  6.9.2 Rabies Treatment Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Amneal Pharmaceuticals Rabies Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Anergis
  6.10.2 Rabies Treatment Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Anergis Rabies Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 RABIES TREATMENT MANUFACTURING COST ANALYSIS

7.1 Rabies Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Rabies Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Rabies Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Rabies Treatment Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES RABIES TREATMENT MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Rabies Treatment Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Rabies Treatment Sales Volume Forecast by Type (2017-2022)
11.3 United States Rabies Treatment Sales Volume Forecast by Application (2017-2022)
11.4 United States Rabies Treatment Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Rabies Treatment
Figure United States Rabies Treatment Market Size (K Units) by Type (2012-2022)
Figure United States Rabies Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure Cell culture vaccines (CCVs) Product Picture
Figure Rabies immunoglobulin (RIGs) Product Picture
Figure Nerve tissue vaccines? (NTVs) Product Picture
Figure United States Rabies Treatment Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Rabies Treatment by Application in 2016
Figure Pre-exposure prophylaxis Examples
Figure Post-exposure prophylaxis Examples
Figure United States Rabies Treatment Market Size (Million USD) by Region (2012-2022)
Figure The West Rabies Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Rabies Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Rabies Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Rabies Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Rabies Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Rabies Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Rabies Treatment Sales (K Units) and Growth Rate (2012-2022)
Figure United States Rabies Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Rabies Treatment Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Rabies Treatment Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Rabies Treatment Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Rabies Treatment Sales Share by Players/Suppliers
Figure 2017 United States Rabies Treatment Sales Share by Players/Suppliers
Figure United States Rabies Treatment Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Rabies Treatment Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Rabies Treatment Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Rabies Treatment Revenue Share by Players/Suppliers
Figure 2017 United States Rabies Treatment Revenue Share by Players/Suppliers
Table United States Market Rabies Treatment Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Rabies Treatment Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Rabies Treatment Market Share of Top 3 Players/Suppliers
Figure United States Rabies Treatment Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Rabies Treatment Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Rabies Treatment Product Category
Table United States Rabies Treatment Sales (K Units) by Region (2012-2017)
Table United States Rabies Treatment Sales Share by Region (2012-2017)
Figure United States Rabies Treatment Sales Share by Region (2012-2017)
Figure United States Rabies Treatment Sales Market Share by Region in 2016
Table United States Rabies Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Rabies Treatment Revenue Share by Region (2012-2017)
Figure United States Rabies Treatment Revenue Market Share by Region (2012-2017)
Figure United States Rabies Treatment Revenue Market Share by Region in 2016
Table United States Rabies Treatment Price (USD/Unit) by Region (2012-2017)
Table United States Rabies Treatment Sales (K Units) by Type (2012-2017)
Table United States Rabies Treatment Sales Share by Type (2012-2017)
Figure United States Rabies Treatment Sales Share by Type (2012-2017)
Figure United States Rabies Treatment Sales Market Share by Type in 2016
Table United States Rabies Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Rabies Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Rabies Treatment by Type (2012-2017)
Figure Revenue Market Share of Rabies Treatment by Type in 2016
Table United States Rabies Treatment Price (USD/Unit) by Types (2012-2017)
Figure United States Rabies Treatment Sales Growth Rate by Type (2012-2017)
Table United States Rabies Treatment Sales (K Units) by Application (2012-2017)
Table United States Rabies Treatment Sales Market Share by Application (2012-2017)
Figure United States Rabies Treatment Sales Market Share by Application (2012-2017)
Figure United States Rabies Treatment Sales Market Share by Application in 2016
Table United States Rabies Treatment Sales Growth Rate by Application (2012-2017)
Figure United States Rabies Treatment Sales Growth Rate by Application (2012-2017)
Table Cadila Healthcare Basic Information List
Table Cadila Healthcare Rabies Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cadila Healthcare Rabies Treatment Sales Growth Rate (2012-2017)
Figure Cadila Healthcare Rabies Treatment Sales Market Share in United States (2012-2017)
Figure Cadila Healthcare Rabies Treatment Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Rabies Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Rabies Treatment Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Rabies Treatment Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Rabies Treatment Revenue Market Share in United States (2012-2017)
Table Merial Basic Information List
Table Merial Rabies Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merial Rabies Treatment Sales Growth Rate (2012-2017)
Figure Merial Rabies Treatment Sales Market Share in United States (2012-2017)
Figure Merial Rabies Treatment Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Rabies Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Rabies Treatment Sales Growth Rate (2012-2017)
Figure Sanofi Rabies Treatment Sales Market Share in United States (2012-2017)
Figure Sanofi Rabies Treatment Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Rabies Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Rabies Treatment Sales Growth Rate (2012-2017)
Figure Merck Rabies Treatment Sales Market Share in United States (2012-2017)
Figure Merck Rabies Treatment Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Rabies Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Rabies Treatment Sales Growth Rate (2012-2017)
Figure Pfizer Rabies Treatment Sales Market Share in United States (2012-2017)
Figure Pfizer Rabies Treatment Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Rabies Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Rabies Treatment Sales Growth Rate (2012-2017)
Figure Bayer Rabies Treatment Sales Market Share in United States (2012-2017)
Figure Bayer Rabies Treatment Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Rabies Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Rabies Treatment Sales Growth Rate (2012-2017)
Figure AstraZeneca Rabies Treatment Sales Market Share in United States (2012-2017)
Figure AstraZeneca Rabies Treatment Revenue Market Share in United States (2012-2017)
Table Amneal Pharmaceuticals Basic Information List
Table Amneal Pharmaceuticals Rabies Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amneal Pharmaceuticals Rabies Treatment Sales Growth Rate (2012-2017)
Figure Amneal Pharmaceuticals Rabies Treatment Sales Market Share in United States (2012-2017)
Figure Amneal Pharmaceuticals Rabies Treatment Revenue Market Share in United States (2012-2017)
Table Anergis Basic Information List
Table Anergis Rabies Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Anergis Rabies Treatment Sales Growth Rate (2012-2017)
Figure Anergis Rabies Treatment Sales Market Share in United States (2012-2017)
Figure Anergis Rabies Treatment Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rabies Treatment
Figure Manufacturing Process Analysis of Rabies Treatment
Figure Rabies Treatment Industrial Chain Analysis
Table Raw Materials Sources of Rabies Treatment Major Players/Suppliers in 2016
Table Major Buyers of Rabies Treatment
Table Distributors/Traders List
Figure United States Rabies Treatment Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Rabies Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Rabies Treatment Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Rabies Treatment Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Rabies Treatment Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Rabies Treatment Sales Volume (K Units) Forecast by Type in 2022
Table United States Rabies Treatment Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Rabies Treatment Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Rabies Treatment Sales Volume (K Units) Forecast by Application in 2022
Table United States Rabies Treatment Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Rabies Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Rabies Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Rabies Treatment Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications